Cell and Gene Therapy

A scientist working in a laboratory at a Novartis location

Cell & Gene Therapy

We are reimagining medicine to power breakthrough innovation in cell and gene therapy

What is cell and gene therapy?

Scientific discoveries such as vaccines and antibiotics changed the course of history. Now cell and gene therapies are creating a new turning point in medicine and how we treat disease.

Learn More

Delivering on the promise of cell and gene therapy for patients

New advances in cell and gene therapies offer the potential to transform medicine. They create an inflection point in our ability to treat and even potentially cure many intractable illnesses.

Learn More

Key focus areas

Currently, there are three key focus areas for development of transformative cell and gene therapies at Novartis: AAV-based therapies, CAR-T cell therapies and CRISPR-based technologies.

Learn More

CAR-T Cell Therapy and Beyond

Novartis is pioneering the way in the class of cell and gene treatment. This includes setting the standard in patient and caregiver support, safety and efficacy, access, and partnerships with healthcare institutions, local health authorities, and academic institutions around the world.

Learn More

Cell and gene facility inaugurated in Switzerland

Novartis opens facility for innovative cell and gene therapies at our Stein manufacturing site in the canton of Aargau.

Learn More

A new era of medicine

Cell and gene therapies could help reduce or eliminate the need for treatments that need to be taken continuously, often for life.

Learn More